These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18754867)

  • 1. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma.
    Nomura Y; Yoshida S; Karube K; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Cancer Sci; 2008 Aug; 99(8):1564-9. PubMed ID: 18754867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients.
    Nomura Y; Karube K; Suzuki R; Ying G; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Cancer Sci; 2008 Feb; 99(2):246-52. PubMed ID: 18271922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
    Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
    Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells.
    Jovanović MP; Jaković L; Bogdanović A; Marković O; Martinović VC; Mihaljević B
    Vojnosanit Pregl; 2009 Sep; 66(9):738-43. PubMed ID: 19877554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
    Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
    Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas.
    Payne CM; Grogan TM; Cromey DW; Bjore CG; Kerrigan DP
    Lab Invest; 1987 Aug; 57(2):200-18. PubMed ID: 3497304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
    McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
    Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
    Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
    Mead GM; Sydes MR; Walewski J; Grigg A; Hatton CS; Pescosta N; Guarnaccia C; Lewis MS; McKendrick J; Stenning SP; Wright D;
    Ann Oncol; 2002 Aug; 13(8):1264-74. PubMed ID: 12181251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.
    Painschab MS; Westmoreland KD; Kasonkanji E; Zuze T; Kaimila B; Waswa P; El-Mallawany NK; Tomoka T; Mulenga M; Montgomery ND; Fedoriw Y; Gopal S
    Blood Adv; 2019 Feb; 3(4):612-620. PubMed ID: 30796065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
    Moleti ML; Testi AM; Giona F; Malandruccolo L; Pescarmona E; Martino P; Paoloni F; Barberi W; Palumbo G; Mandelli F; Foa R
    Leuk Lymphoma; 2007 Mar; 48(3):551-9. PubMed ID: 17454598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
    Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
    Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
    Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
    J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.
    Okudaira T; Nagasaki A; Miyagi T; Taira T; Ohshima K; Takasu N
    Intern Med; 2009; 48(6):475-8. PubMed ID: 19293550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients.
    Koh YW; Hwang HS; Park CS; Yoon DH; Suh C; Huh J
    Leuk Lymphoma; 2015; 56(9):2630-6. PubMed ID: 25573205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
    van Imhoff GW; van der Holt B; MacKenzie MA; Ossenkoppele GJ; Wijermans PW; Kramer MH; van 't Veer MB; Schouten HC; van Marwijk Kooy M; van Oers MH; Raemaekers JM; Sonneveld P; Meulendijks LA; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
    Leukemia; 2005 Jun; 19(6):945-52. PubMed ID: 15800666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells.
    Dos Santos Ferreira AC; Fernandes RA; Kwee JK; Klumb CE
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):317-25. PubMed ID: 22131152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.